Denice Torres - Jan 3, 2022 Form 4 Insider Report for Surface Oncology, Inc. (SURF)

Role
Director
Signature
/s/ Jessica Fees, Attorney-in-Fact
Stock symbol
SURF
Transactions as of
Jan 3, 2022
Transactions value $
$0
Form type
4
Date filed
1/5/2022, 05:00 PM
Previous filing
Nov 17, 2021
Next filing
Jun 6, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SURF Stock Option (Right to Buy) Award $0 +12K $0.00 12K Jan 3, 2022 Common Stock 12K $5.08 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options shall vest in 36 equal monthly installments following December 9, 2021, so long as the grantee remains a director or other service provider of the Company on such dates.